The company's Owkin Socrates platform applies transfer and federated learning to clinical research.
Icon has hired a retired colonel who is moving into the biotech sphere as new president of its subsidiary ClinicalRM.
The SuperHuman library contains over 5,000 hits against each of the 26 Distributed Bio targets in immunology and neurodegeneration.
The $58 million financing round represents biopharma industry's growing interest in genomics data.
JSR Life Sciences’ parent company will pay NT$12 billion ($400 million) for Crown Bioscience International, boosting its global footprint and CRO offerings.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.
The product of a merger of Pluriomics and Axiogenesis, iPSC company Ncardia has signed licensing deals with Roche and Evotec.
X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.
Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.
HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.